| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.25 | 9e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |